1. 1711POpioid-induced constipation in patients with cancer pain in Japan: Prospective observational study using Rome IV OIC diagnostic criteria (OIC-J Study). (23rd October 2018) Authors: Imai, H; Fumita, S; Harada, T; Noriyuki, T; Gamoh, M; Akashi, Y; Sato, H; Kizawa, Y; Tokoro, A Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 425POpioid-induced constipation in patients with cancer pain in Japan (OIC-J study): Patients' self-assessment of the symptoms and the impact. (25th November 2018) Authors: Noriyuki, T; Imai, H; Fumita, S; Harada, T; Gamoh, M; Akashi, Y; Sato, H; Kizawa, Y; Tokoro, A Journal: Annals of oncology Issue: Volume 29(2018)Supplement 9 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 465PTreatment pattern and outcomes of trifluridine/tipiracil therapy for metastatic colorectal cancer in the real-world data from the JFMC50 study. (23rd October 2018) Authors: Kawakami, T; Yamazaki, K; Oki, E; Shimokawa, M; Takahashi, N; Yokota, M; Tokunaga, S; Esaki, T; Gamoh, M; Maeda, A; Tsuji, Y; Sakai, A; Hatanaka, K; Shimada, Y; Shiozawa, M; Komatsu, Y; Okuda, H; Ohue, M; Maehara, Y Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 475PUpdated analysis and exploratory analysis of primary tumor location in the TRICOLORE trial: A randomized phase III trial of S-1 and irinotecan plus bevacizumab versus mFOLFOX6 or CapeOX plus bevacizumab as first-line treatment for metastatic colorectal cancer. (23rd October 2018) Authors: Nakamura, M; Takashima, A; Denda, T; Gamoh, M; Iwanaga, I; Komatsu, Y; Takahashi, M; Ohori, H; Sekikawa, T; Tsuda, M; Kobayashi, Y; Miyamoto, Y; Kotake, M; Ishioka, C; Shimada, K; Sato, A; Yuki, S; Morita, S; Takahashi, S; Yamaguchi, T Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. O-028Long-term effect of peripheral sensory neuropathy (PSN) of 3 or 6 months oxaliplatin-based adjuvant chemotherapy for stage III colon cancer: ACHIEVE as part of the IDEA collaboration. (20th June 2018) Authors: Takeuchi, S; Yoshino, T; Yamanaka, T; Kotaka, M; Manaka, D; Eto, T; Hasegawa, J; Takagane, A; Nakamura, M; Kato, T; Munemoto, Y; Bando, H; Taniguchi, H; Gamoh, M; Shiozawa, M; Saji, S; Maehara, Y; Mizushima, T; Ohtsu, A; Mori, M Journal: Annals of oncology Issue: Volume 29(2018)Supplement 5 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. P-253A phase I/II study of panitumumab combined with TAS-102 in patients (pts) with RAS wild-type (wt) metastatic colorectal cancer (mCRC) refractory to standard chemotherapy: APOLLON study. (20th June 2018) Authors: Yamazaki, K; Yasui, H; Yamaguchi, K; Kagawa, Y; Kuboki, Y; Yoshino, T; Gamoh, M; Komatsu, Y; Satake, H; Goto, M; Tanioka, H; Oki, E; Kotaka, M; Makiyama, A; Denda, T; Soeda, J; Shibya, K; Iwata, M; Oba, K; Kato, T Journal: Annals of oncology Issue: Volume 29(2018)Supplement 5 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. S-1 and irinotecan plus bevacizumab versus mFOLFOX6 or CapeOX plus bevacizumab as first-line treatment in patients with metastatic colorectal cancer (TRICOLORE): a randomized, open-label, phase III, noninferiority trial. (27th December 2017) Authors: Yamada, Y; Denda, T; Gamoh, M; Iwanaga, I; Yuki, S; Shimodaira, H; Nakamura, M; Yamaguchi, T; Ohori, H; Kobayashi, K; Tsuda, M; Kobayashi, Y; Miyamoto, Y; Kotake, M; Shimada, K; Sato, A; Morita, S; Takahashi, S; Komatsu, Y; Ishioka, C Journal: Annals of oncology Issue: Volume 29:Number 3(2018) Page Start: 624 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗